{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:40:47Z","timestamp":1790779247147,"version":"4.1.0"},"reference-count":47,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Inozyme Pharma, Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>Generalized arterial calcification of infancy, pseudoxanthoma elasticum, autosomal recessive hypophosphatemic rickets type 2, and hypophosphatasia are rare inherited disorders associated with altered plasma levels of inorganic pyrophosphate (PPi). In this study, we aimed to establish a reference range for plasma PPi in the pediatric population, which would be essential to support its use as a biomarker in children with mineralization disorders.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Plasma samples were collected from 200 children aged 1 day to 18 years who underwent blood testing for medical conditions not affecting plasma PPi levels. PPi was measured in proband plasma utilizing a validated adenosine triphosphate (ATP) sulfurylase method.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The analytical sensitivity of the ATP sulfurylase assay consisted of 0.15 to 10 \u00b5M PPi. Inter- and intra-assay coefficients of variability on identical samples were below 10%. The standard range of PPi in the blood plasma of children and adolescents aged 0 to 18 years was calculated as 2.36 to 4.44 \u00b5M, with a median of 3.17 \u00b5M, with no difference between male and female probands. PPi plasma levels did not differ significantly in different pediatric age groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Conclusions<\/jats:title>\n                  <jats:p>Our results yielded no noteworthy discrepancy to the reported standard range of plasma PPi in adults (2-5 \u00b5M). We propose the described ATP sulfurylase method as a diagnostic tool to measure PPi levels in plasma as a biomarker in the pediatric population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgab615","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T09:59:05Z","timestamp":1631181545000},"page":"109-118","source":"Crossref","is-referenced-by-count":28,"title":["A Reference Range for Plasma Levels of Inorganic Pyrophosphate in Children Using the ATP Sulfurylase Method"],"prefix":"10.1210","volume":"107","author":[{"given":"Eva","family":"Bernhard","sequence":"first","affiliation":[{"name":"Department of General Pediatrics, Muenster University Children\u2019s Hospital, Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Nitschke","sequence":"additional","affiliation":[{"name":"Department of General Pediatrics, Muenster University Children\u2019s Hospital, Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gus","family":"Khursigara","sequence":"additional","affiliation":[{"name":"Inozyme Pharma, Boston,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Sabbagh","sequence":"additional","affiliation":[{"name":"Inozyme Pharma, Boston,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbao","family":"Wang","sequence":"additional","affiliation":[{"name":"National Jewish Health Advanced Diagnostic Laboratories, Denver, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2385-4159","authenticated-orcid":false,"given":"Frank","family":"Rutsch","sequence":"additional","affiliation":[{"name":"Department of General Pediatrics, Muenster University Children\u2019s Hospital, Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"2021121823150657400_CIT0001","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/1529-0131(197605\/06)19:3+<465::AID-ART1780190722>3.0.CO;2-#","article-title":"Metabolism of inorganic pyrophosphate (PPi)","volume":"19","author":"Russell","year":"1976","journal-title":"Arthritis Rheum."},{"issue":"3","key":"2021121823150657400_CIT0002","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11302-012-9305-8","article-title":"ATP synthesis and storage","volume":"8","author":"Bonora","year":"2012","journal-title":"Purinergic Signal."},{"key":"2021121823150657400_CIT0003","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fcvm.2018.00196","article-title":"Endogenous calcification inhibitors in the prevention of vascular calcification: a consensus statement from the COST Action EuroSoftCalcNet","volume":"5","author":"B\u00e4ck","year":"2018","journal-title":"Front Cardiovasc Med."},{"issue":"1","key":"2021121823150657400_CIT0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-9861(84)90356-4","article-title":"Can biological calcification occur in the presence of pyrophosphate?","volume":"231","author":"Meyer","year":"1984","journal-title":"Arch Biochem Biophys."},{"issue":"6","key":"2021121823150657400_CIT0005","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/ki.2013.521","article-title":"Vascular calcification is dependent on plasma levels of pyrophosphate","volume":"85","author":"Lomashvili","year":"2014","journal-title":"Kidney Int."},{"issue":"1","key":"2021121823150657400_CIT0006","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00257112","article-title":"Aggregation of calcium oxalate crystals: effect of urine and various inhibitors","volume":"5","author":"Felix","year":"1977","journal-title":"Urol Res."},{"issue":"5","key":"2021121823150657400_CIT0007","first-page":"1227","article-title":"Mutant Enpp1asj mice as a model for generalized arterial calcification of infancy","volume":"6","author":"Li","year":"2013","journal-title":"Dis Model Mech."},{"issue":"2","key":"2021121823150657400_CIT0008","doi-asserted-by":"crossref","first-page":"e32177","DOI":"10.1371\/journal.pone.0032177","article-title":"Altered bone development and an increase in FGF-23 expression in Enpp1\u2212\/\u2212 mice","volume":"7","author":"Mackenzie","year":"2012","journal-title":"PLoS One."},{"issue":"1","key":"2021121823150657400_CIT0009","doi-asserted-by":"crossref","first-page":"7786","DOI":"10.1038\/s41598-017-07341-2","article-title":"Enpp1 is an anti-aging factor that regulates Klotho under phosphate overload conditions","volume":"7","author":"Watanabe","year":"2017","journal-title":"Sci Rep."},{"issue":"9","key":"2021121823150657400_CIT0010","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1161\/ATVBAHA.114.304017","article-title":"ABCC6-mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation-brief report","volume":"34","author":"Jansen","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"5","key":"2021121823150657400_CIT0011","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/ATVBAHA.113.302943","article-title":"Disseminated arterial calcification and enhanced myogenic response are associated with abcc6 deficiency in a mouse model of pseudoxanthoma elasticum","volume":"34","author":"Kauffenstein","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"4","key":"2021121823150657400_CIT0012","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1086\/323704","article-title":"A spectrum of ABCC6 mutations is responsible for pseudoxanthoma elasticum","volume":"69","author":"Le Saux","year":"2001","journal-title":"Am J Hum Genet."},{"issue":"3","key":"2021121823150657400_CIT0013","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ajmg.a.37991","article-title":"Molecular and clinical analysis of ALPL in a cohort of patients with suspicion of hypophosphatasia","volume":"173","author":"Tenorio","year":"2017","journal-title":"Am J Med Genet A."},{"issue":"5","key":"2021121823150657400_CIT0014","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI106589","article-title":"Inorganic pyrophosphate in plasma in normal persons and patients with hypophosphatasia, osteogenesis imperfecta, and other disorders of bone","volume":"50","author":"Russell","year":"1971","journal-title":"J Clin Invest."},{"issue":"2","key":"2021121823150657400_CIT0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(65)91422-4","article-title":"Excretion of inorganic pyrophosphate in hypophosphatasia","volume":"1965","author":"Russell","year":"1965","journal-title":"Lancet."},{"issue":"10","key":"2021121823150657400_CIT0016","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1651-2227.2000.tb00747.x","article-title":"Low levels of urinary inorganic pyrophosphate indicating systemic pyrophosphate deficiency in a boy with idiopathic infantile arterial calcification","volume":"89","author":"Rutsch","year":"2000","journal-title":"Acta Paediatr."},{"issue":"2","key":"2021121823150657400_CIT0017","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/CIRCGENETICS.108.797704","article-title":"Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy","volume":"1","author":"Rutsch","year":"2008","journal-title":"Circ Cardiovasc Genet."},{"issue":"2","key":"2021121823150657400_CIT0018","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1444-0938.2010.00559.x","article-title":"Pseudoxanthoma elasticum, ocular manifestations, complications and treatment","volume":"94","author":"Georgalas","year":"2011","journal-title":"Clin Exp Optom."},{"issue":"3","key":"2021121823150657400_CIT0019","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5582\/irdr.2015.01014","article-title":"Pseudoxanthoma elasticum and skin: clinical manifestations, histopathology, pathomechanism, perspectives of treatment","volume":"4","author":"Marconi","year":"2015","journal-title":"Intractable Rare Dis Res."},{"key":"2021121823150657400_CIT0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fgene.2013.00004","article-title":"The vascular phenotype in Pseudoxanthoma elasticum and related disorders: contribution of a genetic disease to the understanding of vascular calcification","volume":"4","author":"Lefth\u00e9riotis","year":"2013","journal-title":"Front Genet."},{"issue":"5","key":"2021121823150657400_CIT0021","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00424-005-0039-0","article-title":"ABCC6 and pseudoxanthoma elasticum","volume":"453","author":"Bergen","year":"2007","journal-title":"Pflugers Arch."},{"issue":"4","key":"2021121823150657400_CIT0022","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1034\/j.1600-0625.2001.100401.x","article-title":"Molecular genetics of pseudoxanthoma elasticum","volume":"10","author":"Ringpfeil","year":"2001","journal-title":"Exp Dermatol."},{"issue":"1","key":"2021121823150657400_CIT0023","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ajmg.a.33162","article-title":"An unusual severe vascular case of pseudoxanthoma elasticum presenting as generalized arterial calcification of infancy","volume":"152A","author":"Le Boulanger","year":"2010","journal-title":"Am J Med Genet A."},{"issue":"1","key":"2021121823150657400_CIT0024","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ajhg.2011.11.020","article-title":"Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6","volume":"90","author":"Nitschke","year":"2012","journal-title":"Am J Hum Genet."},{"key":"2021121823150657400_CIT0025","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.metabol.2017.08.013","article-title":"Hypophosphatasia","volume":"82","author":"Mornet","year":"2018","journal-title":"Metabolism."},{"issue":"4","key":"2021121823150657400_CIT0026","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.14","article-title":"Hypophosphatasia\u2014aetiology, nosology, pathogenesis, diagnosis and treatment","volume":"12","author":"Whyte","year":"2016","journal-title":"Nat Rev Endocrinol."},{"issue":"4","key":"2021121823150657400_CIT0027","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","article-title":"Alkaline phosphatase and hypophosphatasia","volume":"98","author":"Mill\u00e1n","year":"2016","journal-title":"Calcif Tissue Int."},{"issue":"24","key":"2021121823150657400_CIT0028","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1161\/CIRCULATIONAHA.112.000571","article-title":"Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment","volume":"127","author":"Villa-Bellosta","year":"2013","journal-title":"Circulation."},{"issue":"1","key":"2021121823150657400_CIT0029","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/clinchem\/21.1.104","article-title":"Increased inorganic serum pyrophosphate in serum and urine of patients with osteogenesis imperfecta","volume":"21","author":"Armstrong","year":"1975","journal-title":"Clin Chem."},{"issue":"2","key":"2021121823150657400_CIT0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/art.1780160206","article-title":"Articular chondrocalcinosis. Microanalysis of pyrophosphate (PPi) in synovial fluid and plasma","volume":"16","author":"Altman","year":"1973","journal-title":"Arthritis Rheum."},{"issue":"2","key":"2021121823150657400_CIT0031","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/0003-2697(74)90407-2","article-title":"Measurement of inorganic pyrophosphate in biological fluids and bone tissues","volume":"61","author":"Cartier","year":"1974","journal-title":"Anal Biochem."},{"issue":"2","key":"2021121823150657400_CIT0032","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0009-8981(76)90061-9","article-title":"A rapid, enzymatic assay for measurement of inorganic pyrophosphate in biological samples","volume":"66","author":"Lust","year":"1976","journal-title":"Clin Chim Acta."},{"issue":"8","key":"2021121823150657400_CIT0033","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/art.1780220812","article-title":"Quantification of human plasma inorganic pyrophosphate. I. Normal values in osteoarthritis and calcium pyrophosphate dihydrate crystal deposition disease","volume":"22","author":"Ryan","year":"1979","journal-title":"Arthritis Rheum."},{"issue":"8","key":"2021121823150657400_CIT0034","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1172\/JCI107369","article-title":"Measurement of inorganic pyrophosphate in biological fluids. Elevated levels in some patients with osteoarthritis, pseudogout, acromegaly, and uremia","volume":"52","author":"Silcox","year":"1973","journal-title":"J Clin Invest."},{"issue":"1","key":"2021121823150657400_CIT0035","first-page":"51","article-title":"The urinary excretion of inorganic pyrophosphate by normal subjects and patients with renal calculus","volume":"31","author":"Russell","year":"1966","journal-title":"Clin Sci."},{"issue":"3","key":"2021121823150657400_CIT0036","first-page":"365","article-title":"Variation in plasma and urinary inorganic phosphate and pyrophosphate in normal subjects and in patients with acromegaly or osteoarthritis","volume":"7","author":"Camerlain","year":"1980","journal-title":"J Rheumatol."},{"issue":"7342","key":"2021121823150657400_CIT0037","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0140-6736(64)91267-X","article-title":"Effect of orthophosphate on urinary pyrophosphate excretion and the prevention of urolithiasis","volume":"1","author":"Fleisch","year":"1964","journal-title":"Lancet."},{"key":"2021121823150657400_CIT0038","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1464-410X.1965.tb09615.x","article-title":"The effect of oral phosphate in patients with recurrent urinary calculus","volume":"37","author":"Edwards","year":"1965","journal-title":"Br J Urol."},{"key":"2021121823150657400_CIT0039","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000401568","article-title":"Serum alkaline phosphatase, serum pyrophosphatase, phosphorylethanolamine and inorganic pyrophosphate in plasma and urine. A genetic and clinical study of hypophosphatasia","volume":"10","author":"S\u00f8rensen","year":"1978","journal-title":"Monogr Hum Genet."},{"issue":"2","key":"2021121823150657400_CIT0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1432-1033.1970.tb01004.x","article-title":"Isotope derivative method for determination of microquantities of inorganic pyrophosphate in biological material","volume":"15","author":"Flodgaard","year":"1970","journal-title":"Eur J Biochem."},{"issue":"2","key":"2021121823150657400_CIT0041","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0003-2697(71)90226-0","article-title":"New radiochemical method for assay of inorganic pyrophosphatase","volume":"44","author":"Cartier","year":"1971","journal-title":"Anal Biochem."},{"issue":"1","key":"2021121823150657400_CIT0042","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0003-2697(68)90037-7","article-title":"An enzymic method for determination of inorganic pyrophosphate and its use as an assay for RNA polymerase","volume":"26","author":"Johnson","year":"1968","journal-title":"Anal Biochem."},{"issue":"3","key":"2021121823150657400_CIT0043","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0009-8981(78)90389-3","article-title":"The estimation of pyrophosphate in urine with uridine-5\u2019-diphosphoglucose pyrophosphorylase","volume":"86","author":"Sutor","year":"1978","journal-title":"Clin Chim Acta."},{"issue":"2","key":"2021121823150657400_CIT0044","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ab.2007.04.023","article-title":"A multienzyme bioluminescent time-resolved pyrophosphate assay","volume":"367","author":"Sun","year":"2007","journal-title":"Anal Biochem."},{"issue":"7","key":"2021121823150657400_CIT0045","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1172\/JCI107336","article-title":"Identification of inorganic pyrophosphate in human platelets and its release on stimulation with thrombin","volume":"52","author":"Silcox","year":"1973","journal-title":"J Clin Invest."},{"issue":"4","key":"2021121823150657400_CIT0046","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.1780140411","article-title":"Sequential changes in human polymorphonuclear leukocytes after urate crystal phagocytosis. An electron microscopic study","volume":"14","author":"Schumacher","year":"1971","journal-title":"Arthritis Rheum."},{"issue":"2","key":"2021121823150657400_CIT0047","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/oxfordjournals.bmb.a071484","article-title":"Antithrombin III and heparin","volume":"34","author":"Barrowcliffe","year":"1978","journal-title":"Br Med Bull."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab615\/40348477\/dgab615.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/1\/109\/41819425\/dgab615.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/1\/109\/41819425\/dgab615.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T23:17:43Z","timestamp":1639869463000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/1\/109\/6366972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,9,9]]},"published-print":{"date-parts":[[2022,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab615","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,9,9]]}}}